XLV and IYZ remain under weights. XLV improved a lot but the chart is worse than other sectors and the accumulation model remains weak. Note that there is no Biotech in XLV, so the improvement there is not helping this area.
Sorry this page is available to subscribers only. If you're not a subscriber why not join today?